Gil Leibowitz

9.7k total citations
53 papers, 3.0k citations indexed

About

Gil Leibowitz is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Gil Leibowitz has authored 53 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Surgery, 26 papers in Molecular Biology and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Gil Leibowitz's work include Pancreatic function and diabetes (38 papers), Metabolism, Diabetes, and Cancer (17 papers) and Diabetes and associated disorders (13 papers). Gil Leibowitz is often cited by papers focused on Pancreatic function and diabetes (38 papers), Metabolism, Diabetes, and Cancer (17 papers) and Diabetes and associated disorders (13 papers). Gil Leibowitz collaborates with scholars based in Israel, United States and Sweden. Gil Leibowitz's co-authors include Erol Cerasi, Ν. Kaiser, Nurit Kaiser, Yafa Ariav, David J. Gross, Mali Ketzinel‐Gilad, Fred Levine, Etty Bachar-Wikström, Jakob D. Wikström and Salvador Soriano and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Neuroscience.

In The Last Decade

Gil Leibowitz

53 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gil Leibowitz Israel 30 1.5k 1.3k 885 582 579 53 3.0k
Chong Wee Liew United States 28 1.5k 1.0× 1.6k 1.2× 830 0.9× 690 1.2× 751 1.3× 60 3.3k
Masatoshi Kikuchi Japan 36 957 0.6× 2.1k 1.6× 1.0k 1.1× 327 0.6× 790 1.4× 77 3.8k
Raphaël Roduit Switzerland 24 1.6k 1.0× 1.4k 1.0× 922 1.0× 582 1.0× 817 1.4× 40 3.2k
Joachim Størling Denmark 29 1.4k 0.9× 1.2k 0.9× 736 0.8× 982 1.7× 385 0.7× 81 3.2k
Jiang Hu United States 23 1.6k 1.1× 1.2k 0.9× 799 0.9× 791 1.4× 592 1.0× 54 2.8k
Hiroto Furuta Japan 32 1.8k 1.2× 1.5k 1.1× 1.0k 1.2× 1.2k 2.1× 547 0.9× 98 3.7k
Sarah A. Tersey United States 29 1.2k 0.8× 917 0.7× 558 0.6× 742 1.3× 364 0.6× 77 2.3k
Ulupi S. Jhala United States 20 1.5k 1.0× 2.2k 1.7× 781 0.9× 855 1.5× 1.2k 2.0× 28 4.0k
Asllan Gjinovci Switzerland 29 2.0k 1.3× 1.4k 1.0× 1.2k 1.4× 651 1.1× 484 0.8× 52 3.1k
David A. Jacobson United States 31 1.1k 0.8× 1.2k 0.9× 606 0.7× 524 0.9× 294 0.5× 74 2.4k

Countries citing papers authored by Gil Leibowitz

Since Specialization
Citations

This map shows the geographic impact of Gil Leibowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Leibowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Leibowitz more than expected).

Fields of papers citing papers by Gil Leibowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gil Leibowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Leibowitz. The network helps show where Gil Leibowitz may publish in the future.

Co-authorship network of co-authors of Gil Leibowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Gil Leibowitz. A scholar is included among the top collaborators of Gil Leibowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gil Leibowitz. Gil Leibowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Permyakova, Anna, Liad Hinden, Saja Baraghithy, et al.. (2024). Renal Mitochondrial ATP Transporter Ablation Ameliorates Obesity-Induced CKD. Journal of the American Society of Nephrology. 35(3). 281–298. 9 indexed citations
2.
Vázquez, Patricia, Eva Tudurí, Mercedes Mirasierra, et al.. (2021). The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice. Diabetologia. 65(3). 490–505. 11 indexed citations
3.
Karmi, Ola, Yang‐Sung Sohn, Henri‐Baptiste Marjault, et al.. (2021). A Combined Drug Treatment That Reduces Mitochondrial Iron and Reactive Oxygen Levels Recovers Insulin Secretion in NAF-1-Deficient Pancreatic Cells. Antioxidants. 10(8). 1160–1160. 11 indexed citations
4.
Hinden, Liad, Shiran Udi, Adi Drori, et al.. (2017). Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy. Journal of the American Society of Nephrology. 29(2). 434–448. 65 indexed citations
5.
Kogot‐Levin, Aviram, Ann Saada, Gil Leibowitz, et al.. (2016). Upregulation of Mitochondrial Content in Cytochrome c Oxidase Deficient Fibroblasts. PLoS ONE. 11(10). e0165417–e0165417. 28 indexed citations
6.
Malakar, Pushkar, Ayat Hija, Gil Leibowitz, et al.. (2016). Insulin receptor alternative splicing is regulated by insulin signaling and modulates beta cell survival. Scientific Reports. 6(1). 31222–31222. 58 indexed citations
7.
Stienstra, Rinke, Yulia Haim, Yael Riahi, et al.. (2014). Autophagy in adipose tissue and the beta cell: implications for obesity and diabetes. Diabetologia. 57(8). 1505–1516. 79 indexed citations
8.
9.
10.
Leibowitz, Gil, Erol Cerasi, & Mali Ketzinel‐Gilad. (2008). The role of mTOR in the adaptation and failure of β‐cells in type 2 diabetes. Diabetes Obesity and Metabolism. 10(s4). 157–169. 61 indexed citations
11.
Fraenkel, Merav, et al.. (2008). Scanning Electron Microscopic Analysis of Intramyocellular Lipid Droplets in an Animal Model of Type 2 Diabetes. Obesity. 16(3). 695–699. 13 indexed citations
12.
Ariav, Yafa, et al.. (2006). Regulation of Insulin Secretion and Proinsulin Biosynthesis by Succinate. Endocrinology. 147(11). 5110–5118. 23 indexed citations
13.
Kaiser, Ν., et al.. (2003). Glucotoxicity and β-Cell Failure in Type 2 Diabetes Mellitus. Journal of Pediatric Endocrinology and Metabolism. 16(1). 5–22. 172 indexed citations
14.
Leibowitz, Gil, Gökhan Üçkaya, Andrei I. Oprescu, et al.. (2002). Glucose-Regulated Proinsulin Gene Expression Is Required for Adequate Insulin Production during Chronic Glucose Exposure. Endocrinology. 143(9). 3214–3220. 30 indexed citations
15.
Cerasi, Erol, Ν. Kaiser, & Gil Leibowitz. (2000). Diabète de type 2 et apoptose des cellules b. Diabetes & Metabolism. 26. 13–16. 16 indexed citations
16.
Levine, Fred & Gil Leibowitz. (1999). Towards gene therapy of diabetes mellitus. Molecular Medicine Today. 5(4). 165–171. 38 indexed citations
17.
Bar, Merav, et al.. (1997). Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel‐Lindau and RET genes. Clinical Endocrinology. 47(6). 707–712. 42 indexed citations
18.
Leibowitz, Gil, Anat Tsur, Mohammad Salameh, et al.. (1996). Pre‐clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clinical Endocrinology. 44(6). 717–722. 137 indexed citations
19.
Leibowitz, Gil, Alon J. Pikarsky, Ζ. Josefsberg, et al.. (1996). Normal proinsulin processing despite beta-cell dysfunction in persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis). Diabetologia. 39(11). 1338–1344. 8 indexed citations
20.
Leibowitz, Gil, et al.. (1995). Thrombasthenia ‐ a rare cause of Sheehan's syndrome. Acta Obstetricia Et Gynecologica Scandinavica. 74(6). 482–484. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chong Wee Liew Breakdown of academic impact, for papers by Masatoshi Kikuchi Breakdown of academic impact, for papers by Raphaël Roduit Breakdown of academic impact, for papers by Joachim Størling Breakdown of academic impact, for papers by Jiang Hu Breakdown of academic impact, for papers by Hiroto Furuta Breakdown of academic impact, for papers by Sarah A. Tersey Breakdown of academic impact, for papers by Ulupi S. Jhala Breakdown of academic impact, for papers by Asllan Gjinovci Breakdown of academic impact, for papers by David A. Jacobson
Rankless by CCL
2026